COMMUNIQUÉS West-GlobeNewswire
-
Physician Health Programs Skirt the Americans with Disabilities Act, according to the Journal of American Physicians and Surgeons
09/12/2025 -
PathAI's AIM-MASH AI Assist¹ Becomes First AI-Powered Tool to Receive FDA Qualification for MASH Clinical Trials
09/12/2025 -
Natural Remedies Advances GutGard Research With New Study on Appetite and Metabolic Pathways
09/12/2025 -
NADP Report Shows Continued Decline in Dental Benefits Enrollment
09/12/2025 -
Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine
09/12/2025 -
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
09/12/2025 -
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
09/12/2025 -
Dandy Acquires Neem to Accelerate Digital Innovation in Dentistry
09/12/2025 -
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN
09/12/2025 -
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
09/12/2025 -
Meiogenix Forms Strategic Advisory Board of Global AgTech Leaders to Accelerate Crop Breeding Transformation
09/12/2025 -
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds
09/12/2025 -
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
09/12/2025 -
UPDATE -- Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO
09/12/2025 -
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China
09/12/2025 -
Olympia Pharmaceuticals and Wesley Pharmaceuticals Co-Founder Stan Loomis Establishes Scholarship for The Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
09/12/2025 -
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI®▼ (teclistamab) plus DARZALEX® (daratumumab) subcutaneous formulation as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
09/12/2025 -
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
09/12/2025 -
The Therapy Group of Philadelphia Joins the Lumina Therapy Alliance, Expanding a National Network of Premium In-Person Mental Health Practices
09/12/2025
Pages